StockData
Scribe Therapeutics, Inc. logo

Scribe Therapeutics, Inc. (SCTX) stock

SCTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.05−1.72 (-10.91%)

Close on Nov 18, 2026Market cap $34.92MP/E –Yield –

Scribe Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Scribe Therapeutics's shares outstanding was 2M at Jun 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262M–
Q2 FY2025Jun 30, 20252M–

More Scribe Therapeutics figures

See a number that looks wrong?